Related Experiment Video
Updated: Aug 20, 2025

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
Complications and Adverse Events of Gonadal Vein Embolization with Coils
Sergey G Gavrilov1, Nadezhda Y Mishakina1, Oksana I Efremova1
1Department of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, Moscow 119049, Russia.
Insights
Gonadal vein embolization (GVE) for pelvic venous disease (PeVD) effectively reduces chronic pelvic pain (CPP) in most patients. However, GVE is associated with specific complications, including pelvic vein thrombosis, necessitating careful patient selection and monitoring.
Area of Science:
- Interventional Radiology
- Vascular Medicine
- Gynecology
Background:
- The efficacy and safety of gonadal vein embolization (GVE) using coils for treating pelvic venous disease (PeVD) remain incompletely understood.
- Patient and physician expectations are not always met by GVE outcomes, highlighting a need to investigate associated complications.
Purpose of the Study:
- To assess the incidence and causes of complications following GVE with coils in patients diagnosed with PeVD.
- To evaluate the effectiveness of GVE in alleviating chronic pelvic pain (CPP) and identify associated adverse events.
Main Methods:
- A retrospective cohort study involving 150 female patients with PeVD who underwent GVE with coils between 2000 and 2020.
- Complication rates were assessed 30 days post-GVE using the Society for Interventional Radiology (SIR) classification.
- Pain severity was measured using the visual analogue scale (VAS), with duplex ultrasound and CT venography used for follow-up.
Main Results:
- Chronic pelvic pain (CPP) decreased in 72.6% of patients post-GVE (mean VAS from 8.2 to 1.7).
- Post-embolic syndrome (PES) occurred in 22% of patients, resolving within one month, with an overall GVE efficacy of 94.6% after PES resolution.
- Complications were observed in 34.6% of patients, including minor events (hematoma, allergic reactions) and major events (coil protrusion, parametrial/uterine vein thrombosis [21.3%], deep calf vein thrombosis [2.7%]).
Conclusions:
- Gonadal vein embolization (GVE) with coils for PeVD is linked to specific complications, with pelvic vein thrombosis being the most frequent.
- Post-embolization syndrome (PES) should be recognized as a potential adverse event of GVE procedures.
- Despite complications, GVE demonstrates significant efficacy in pain relief for a majority of patients with PeVD.
Abstract:
Background: The efficacy and safety of gonadal vein embolization (GVE) with coils in the treatment of pelvic venous disease (PeVD) has not been fully investigated, and the outcomes after GVE do not always meet expectations of both doctors and patients. The study was aimed at assessing the incidence and causes of the complications after GVE with coils in patients with PeVD. Methods: This retrospective cohort study included 150 female patients with PeVD who underwent GVE with coils in 2000-2020. A total of 4975 patients with chronic pelvic pain (CPP) were examined, of which 1107 patients had the PeVD-related CPP and 305 underwent surgical or endovascular interventions on the gonadal veins. Complication rates were evaluated 30 days after GVE and classified according to the Society for Interventional Radiology (SIR) adverse event classification system. The pain severity before and after GVE was assessed using a visual analogue scale (VAS). All patients underwent duplex ultrasound after GVE, while patients with persisting pain syndrome and suspected perforation of the gonadal vein were also evaluated using computed tomographic venography. Results: At 30 days after GVE, the CPP was decreased in 109 (72.6%) patients (from 8.2 ± 1.5 at baseline to 1.7 ± 0.8 scores, p = 0.0001) and persisted in 41 (27.4%) patients (mean change from 8.1 ± 0.7 at baseline to 7.8 ± 0.4 scores; p = 0.71). Post-embolic syndrome (PES) occurred in 22% of patients and was completely resolved in 1 month after GVE. The efficacy of GVE in the CPP relief after resolving PES was 94.6%. The GVE complications were identified in 52 (34.6%) patients. Minor complications included access-site hematoma (4%) and allergic reactions (1.3%), and major complications included protrusion of coils (5.3%), thrombosis of the parametrial/uterine veins (21.3%) and deep veins of the calf (2.7%). Conclusions: Gonadal vein embolization with coils in the treatment of PeVD is associated with the development of specific complications and adverse events. The most common complication was pelvic vein thrombosis. Post-embolization syndrome should be considered as an adverse event of this procedure.
More Related Videos
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Hemodialysis II: Procedure and Complications

